Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Bente Glintborg; Daniela Di Giuseppe; Johan Karlsson Wallman; Dan C Nordström; Bjorn Gudbjornsson; Merete Lund Hetland; Johan Askling; Gerdur Grondal; Tuulikki Sokka; Sella A Provan; Brigitte Michelsen; Eirik Klami Kristianslund; Lene Dreyer; Thorvardur Jon Love; Ulf Lindström

doi:10.1136/ard-2022-223650

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

PDF +
Supplementary
Material

Psoriatic arthritis

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

Free

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password